ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
批准号:
10710595
负责人:
KEVIN SAUNDERS
金额:
$1124.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2026-09-18
关键词:
Advanced DevelopmentAnimal ModelCOVID-19 vaccineClinicalCommunicable DiseasesContractsDisease OutbreaksEmerging Communicable DiseasesFormulationIndividualSARS coronavirusSafetyToxicologyVaccinesefficacy evaluationefficacy testingimmunogenicitynovel coronaviruspandemic diseaseresponsestability testingvaccine development
中文摘要
支持候选产品的高级开发,以便在故意释放传染病(包括新出现的传染病)之后使用或应对自然发生的传染病暴发。该合同可支持单个疫苗组分的配制和生产,以及动物模型中的稳定性试验、非临床免疫原性和有效性试验、IND启用GLP毒理学、IND提交以及临床安全性和有效性评价。
英文摘要
To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
-
批准号:10788051
-
项目类别:
-
资助金额:$685.82万
-
财政年份:2022
-
负责人:KEVIN SAUNDERS
-
依托单位:
海外基金